Batista DA, Fong LO, Rodríguez TJC, Puente ZE, Pérez MO

Language: Spanish
References: 14
Page: 1284-1294
PDF size: 3189.86 Kb.

ABSTRACT

The effect of the adjuvant Finlay cochleate1 (AFCo1), applied intranasally 4 times in 2 dose levels (50 µg and 100 µg) on plasma concentration of theophylline administered 24 hours after the last application (5 mg/kg intraperitoneally) in Sprague-Dawley rats was evaluated in this study. Application subcutaneously of 2 doses of Freund's complete adjuvant (FCA) was used as positive control of inflammation. Rats receiving AFCo1 had no significant changes in serum theophylline concentration, while those treated with FCA developed local inflammation associated with signs of theophylline toxicity and increased specific G immunoglobulin, plasma concentrations and serum theophylline half-life as compared with the remaining groups. These results show that intranasal AFCo1-induced immunostimulation does not increase pharmacokinetic parameters and theophylline toxicity in the model used.

REFERENCES

1. Renton KW, Gray JD, Hall RI. Decreased elimination of theophyiline after influenza vaccination. Can Med Assoc J.1980; 123: 288-90.

2. Bleau AM, Maurel P, Pichette V, Leblond F, du Souich P. Interleukin-1h, interleukin-6, tumour necrosis factor- á and interferon- g released by a viral infection and an aseptic inflammation reduce CYP1A1,1A2 and 3A6 expression in rabbit hepatocytes. Eur J Pharmacol. 2003; 473:197-206.

3. Projean D, Dautrey S, Vu HK, Groblewski T, Brazier JL, Ducharme J. Selective downregulation of hepatic cytochrome P450 expression and activity in a rat model of inflammatory pain. Pharm Res. 2005; 22: 62-70.

4. Projean D, Lessard E, Ducharme P, Ducharme J. Use of Freund's Complete Adjuvant (FCA) in inflammatory pain models: consequences on the metabolism and pharmacokinetics of the non-peptidic delta receptor agonist SNC80 in the rat. Xenobiotica. 2007; 37(8): 870-88.

5. Yang KH, Jung YS, Lee DY, Lee JH, Kim,YC, Lee MG. Time-dependent effects of Klebsiella pneumoniae Endotoxin (KPLPS) on the pharmacokinetics of theophylline in rats: return of the parameters in 96-hour KPLPS rats to the control levels. Drug Metabol Disp. 2008; 36(5):811-15.

6. Sweetman SC. Martindale: the complete drug reference. 36th. New York: Pharmaceutical Press; 2009.

7. Reed SG, Bertholet S, Coler RN, Friede M. New horizons in adjuvants for vaccine development. Trends Immunol. 2009; (30)1: 23-32.

8. Batista Duharte A, Lindblad E, Oviedo E. Progress in understanding adjuvant immunotoxicity mechanisms. Toxicol Lett. 2011; 203: 97-105.

9. Método de obtención de estructuras cocleares. Composiciones vacunales y adyuvantes basados en estructuras cocleares y sus intermediarios [citado 15 May 2012]. Disponible en: http://www.patentesonline.com.co/metodo-de-obtencion-de-estructuras-cocleares -composiciones-vacunales-y-adyuantes-49101.html

10. Descotes J. Immunomodulating agents and hepatic drugs metabolism enzymes. Drug Metab Rev. 1985; 16(1-2):175-84.

11. Luster M, Simeonova P, Gallucci R, Bruccoleri A, Blazka M, Yucesoy B. Role of inflammation in chemical-induced hepatotoxicity. Toxicol Lett. 2001; 120(1-3): 317_32.

12. Infante JF, Sifontes S, Pérez V, Bracho G, Hernández T, Zayas C,et al. Ensayo de inmunogenicidad y de toxicidad local del cocleato de Neisseria meningitidis en ratas Spregue Dawley. VacciMonitor. 2009; 18(1):1-7.

13. Batista Duharte A, Murillo GJ, Pérez U, Tur NE, Portuondo FD, Pérez O. Evaluación de la irritabilidad en mucosa del adyuvante AFCO1 por el método de HET-CAM. VacciMonitor 2011; 20(1):22-27.

14. Duffus JH, Templeton DM, Nordberg M. Concepts in Toxicology. Cambridge: Royal Society of Chemistry; 2009.